Skip to main content
USCOM LIMITED logo

USCOM LIMITED — Investor Relations & Filings

Ticker · UCM ISIN · AU000000UCM2 LEI · 984500B98CA37D7DTC85 ASX Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2022-07-24 Interim / Quarterly Rep…
Country AU Australia
Listing ASX UCM

About USCOM LIMITED

https://www.uscom.com.au/

Uscom Limited specializes in the development and manufacture of non-invasive cardiovascular and pulmonary monitoring devices. Its core product suite includes the Uscom 1A, an ultrasonic cardiac output monitor that provides real-time hemodynamic data for clinical decision-making in emergency, intensive care, and pediatric settings. The company also produces the BP+ system, which utilizes suprasystolic oscillometry to measure central blood pressure and analyze pulse pressure waves, and the SpiroSonic range of digital ultrasonic spirometers designed for high-fidelity pulmonary function testing. These technologies focus on providing accurate, non-invasive diagnostic information to improve patient outcomes in both hospital and home-care environments. By leveraging advanced ultrasonic technology, the company provides clinicians with rapid, reliable physiological data as an alternative to invasive monitoring methods.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 250.5KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX release titled 'Uscom 4C Quarterly Cash Report to 30 June 2022' and includes detailed quarterly cash flow information in the form of an Appendix 4C, which is a standard quarterly cash flow report required by the ASX Listing Rules (Rule 4.7B). The report contains actual financial data such as cash on hand, revenue, expenditure, and cash flow statements for the quarter ended 30 June 2022. It also includes management commentary on the quarter's performance and outlook. The presence of substantive financial data and the quarterly period covered clearly identify this as an Interim / Quarterly Report. It is not a brief announcement or a certification, but a comprehensive quarterly financial report with analysis and data. Therefore, the correct classification is 'IR' (Interim / Quarterly Report).
2022-07-24 English
China NMPA Accepts Registration for SpiroSonic Spirometers 4 pages 602.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing the acceptance by the China NMPA (National Medical Products Administration) of registration for Uscom's SpiroSonic spirometer devices. It details the regulatory acceptance, product background, commercial implications, and company information. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory announcement about product registration and market entry rather than a financial report or management discussion. It is not a report publication announcement since it contains substantive information about the regulatory acceptance and business impact. Therefore, the document fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-07-20 English
Change of Director's Interest Notice - Phillips 3 pages 157.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and dates. This is a clear report of personal share transactions by a company director. The document length is 3489 characters, which is typical for such notices. There is no indication of financial results, management discussion, or other report types. Therefore, this document fits the definition of Director's Dealing (DIRS).
2022-07-05 English
Application for quotation of securities - UCM 7 pages 30.1KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX (Australian Securities Exchange) by USCOM LIMITED. It details the issuance of additional ordinary fully paid shares and share rights, including the number of securities, issue dates, and the purpose of issuance (e.g., remuneration in lieu of cash). The document references compliance with ASX Listing Rules and Corporations Act provisions. It is not a financial report, earnings release, or management discussion but rather a formal announcement related to capital changes and securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is a full announcement, not a brief notice or report publication announcement.
2022-07-04 English
Cleansing notice 1 page 89.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement titled 'NOTICE GIVEN UNDER section 708A(5) OF THE CORPORATIONS ACT'. It states that the company issued shares without disclosure under Part 6D.2 of the Act and confirms compliance with relevant provisions. The document is short (1309 characters) and serves as a regulatory notice about share issuance and compliance, not a full financial report or detailed filing. It does not contain financial statements or detailed analysis, nor is it a report publication announcement. This fits the description of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-07-04 English
Asia and ASEAN Distribution with BD Manager Appointment 3 pages 91.6KB
Board/Management Information Classification · 95% confidence The document is an ASX release announcing the appointment of a new South East Asian Distribution and Business Development Manager and outlining the company's strategic expansion in the Asia and ASEAN region. It discusses operational and strategic updates, including regulatory approvals and partnerships, but does not contain financial statements, earnings data, or detailed financial analysis. It is not a full annual or interim report, nor is it a call transcript or audit report. The content focuses on management appointment and business development activities. Therefore, the document fits best under Board/Management Information (MANG) as it announces a key management appointment and strategic business development update. The document length (over 10,000 characters) and detailed content support this classification with high confidence.
2022-06-26 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.